Running Title: GP IIb/IIIa inhibitor and cardiac events

[1]  K. Mahaffey,et al.  Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Non-ST Segment Elevation Acute Coronary Syndromes , 2012, Drugs.

[2]  R. Becker.  Emerging paradigms, platforms, and unifying themes in biomarker science. , 2007, Journal of the American College of Cardiology.

[3]  P. Libby,et al.  Vascular Biomarkers and Surrogates in Cardiovascular Disease , 2006, Circulation.

[4]  H. Ekmekçi,et al.  Vitronectin in atherosclerotic disease. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[5]  A. Kastrati,et al.  Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Patients With Chronic Stable Angina , 2005, Circulation.

[6]  M. Hadamitzky,et al.  Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. , 2003, American heart journal.

[7]  D. Morrow,et al.  Troponins in acute coronary syndromes. , 2004, Progress in cardiovascular diseases.

[8]  H. Ekmekçi,et al.  Plasma Vitronectin Levels in Patients with Coronary Atherosclerosis are Increased and Correlate with Extent of Disease , 2002, Journal of Thrombosis and Thrombolysis.

[9]  M. Kazatchkine,et al.  Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries , 2004, Virchows Archiv A.

[10]  C. Heeschen,et al.  Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes , 2003, Circulation.

[11]  P. Libby,et al.  Soluble CD40L: Risk Prediction After Acute Coronary Syndromes , 2003, Circulation.

[12]  R. Read,et al.  How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration , 2003, Nature Structural Biology.

[13]  C. Heeschen,et al.  Serum Level of the Antiinflammatory Cytokine Interleukin-10 Is an Important Prognostic Determinant in Patients With Acute Coronary Syndromes , 2003, Circulation.

[14]  L. McIntire,et al.  Platelet–monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with αIIbβ3 and αMβ2, in coronary stenting , 2003 .

[15]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[16]  B. Coller.  Binding of Abciximab to αVβ3 and Activated αMβ2 Receptors: With a Review of Platelet-Leukocyte Interactions , 1999, Thrombosis and Haemostasis.

[17]  B. Coller.  Potential non-glycoprotein IIb/IIIa effects of abciximab. , 1999, American heart journal.

[18]  V. Fuster,et al.  Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. , 1999, JAMA.

[19]  R. Jordan,et al.  Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primates. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[20]  R. Jordan,et al.  Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and αvβ3 Integrins , 1998 .

[21]  J. Bonnet,et al.  Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[22]  E. Topol.  Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence. , 1998, Circulation.

[23]  D. Seiffert,et al.  Role of vitronectin and its receptors in haemostasis and vascular remodeling. , 1998, Thrombosis research.

[24]  A. Siegbahn,et al.  Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 1997, Circulation.

[25]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[26]  T. Tedder.  Cell-surface receptor shedding: a means of regulating function. , 1991, American journal of respiratory cell and molecular biology.

[27]  K. Preissner,et al.  Structure and biological role of vitronectin. , 1991, Annual review of cell biology.

[28]  H. Rus,et al.  Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis. , 1987, Atherosclerosis.

[29]  M. Davies,et al.  Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. , 1986, Circulation.